- Home
- APRE vs EKSO Comparison
APRE vs EKSO Comparison
Compare APRE & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- EKSO
- Stock Information
- Founded
- APRE 2006
- EKSO 2005
- Country
- APRE United States
- EKSO United States
- Employees
- APRE N/A
- EKSO N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- EKSO Medical/Dental Instruments
- Sector
- APRE Health Care
- EKSO Health Care
- Exchange
- APRE Nasdaq
- EKSO Nasdaq
- Market Cap
- APRE 10.0M
- EKSO 11.7M
- IPO Year
- APRE 2019
- EKSO N/A
- Fundamental
- Price
- APRE $1.71
- EKSO $3.44
- Analyst Decision
- APRE Strong Buy
- EKSO Strong Buy
- Analyst Count
- APRE 2
- EKSO 2
- Target Price
- APRE $15.50
- EKSO $37.50
- AVG Volume (30 Days)
- APRE 50.9K
- EKSO 260.6K
- Earning Date
- APRE 08-11-2025
- EKSO 07-28-2025
- Dividend Yield
- APRE N/A
- EKSO N/A
- EPS Growth
- APRE N/A
- EKSO N/A
- EPS
- APRE N/A
- EKSO N/A
- Revenue
- APRE $1,284,475.00
- EKSO $17,544,000.00
- Revenue This Year
- APRE N/A
- EKSO $0.20
- Revenue Next Year
- APRE N/A
- EKSO $42.29
- P/E Ratio
- APRE N/A
- EKSO N/A
- Revenue Growth
- APRE 33.27
- EKSO N/A
- 52 Week Low
- APRE $1.41
- EKSO $2.73
- 52 Week High
- APRE $5.01
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- APRE 52.34
- EKSO 39.67
- Support Level
- APRE $1.48
- EKSO $2.73
- Resistance Level
- APRE $1.91
- EKSO $4.03
- Average True Range (ATR)
- APRE 0.16
- EKSO 0.34
- MACD
- APRE -0.00
- EKSO 0.00
- Stochastic Oscillator
- APRE 63.14
- EKSO 46.67
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.